Drug Information

Drug General Information
Drug ID
D0O2RN
Former ID
DNC004507
Drug Name
N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526204]
Formula
C17H19N3O
Canonical SMILES
CC1=CC=C(C=C1)C(=O)NC(=NCCC2=CC=CC=C2)N
InChI
1S/C17H19N3O/c1-13-7-9-15(10-8-13)16(21)20-17(18)19-12-11-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H3,18,19,20,21)
InChIKey
ZVURELUSYUBEQF-UHFFFAOYSA-N
PubChem Compound ID
22149251
Target and Pathway
Target(s) Sodium channel protein type 5 subunit alpha Target Info Inhibitor [526204]
KEGG Pathway Adrenergic signaling in cardiomyocytes
PathWhiz Pathway Muscle/Heart Contraction
Reactome Interaction between L1 and Ankyrins
WikiPathways SIDS Susceptibility Pathways
Cardiac Progenitor Differentiation
References
Ref 526204Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.
Ref 526204Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.